4.7 Article

Activated pregnane X receptor inhibits cervical cancer cell proliferation and tumorigenicity by inducing G2/M cell-cycle arrest

Journal

CANCER LETTERS
Volume 347, Issue 1, Pages 88-97

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.01.026

Keywords

Pregnane X receptor; Cervical cancer; Proliferation; Cell cycle; Tumorigenicity

Categories

Funding

  1. Guangdong Natural Science Foundation [S2012010010955]
  2. China Postdoctoral Science Foundation [2012M510200]
  3. central government special funds supporting the development of local colleges and universities

Ask authors/readers for more resources

Pregnane X receptor (PXR) regulates cell proliferation and carcinogenesis in female reproductive tissue. We showed that PXR was expressed in cervical cells and tissue samples. PXR were lower or greatly diminished in cancer tissues compared to normal control. Functionally, activation of human PXR by rifampicin or ectopic expression of constitutively-activated human VP-PXR inhibited cervical cell proliferation. Constitutively-activated VP-PXR attenuated CaSki and HeLa xenograft tumor growth in nude mice compared with control. The cellular proliferation inhibition of PXR by causing G2/M cell-cycle arrest is involved up-regulation of Cullin1-3, MAD2L1, and down-regulation of ANAPC2 and CDKN1A. Our data suggests that PXR signaling inhibits tumor cell proliferation in vitro and cervical carcinoma growth in vivo. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Farnesoid X Receptor Ablation Sensitizes Mice to Hepatitis B Virus X Protein-Induced Hepatocarcinogenesis

Yongdong Niu, Meishu Xu, Betty L. Slagle, Haihua Huang, Song Li, Grace L. Guo, Ganggang Shi, Wenxin Qin, Wen Xie

HEPATOLOGY (2017)

Article Pharmacology & Pharmacy

Activation of Constitutive Androstane Receptor Ameliorates Renal Ischemia-Reperfusion-Induced Kidney and Liver Injury

You-Jin Choi, Dong Zhou, Anne Caroline S. Barbosa, Yongdong Niu, Xiudong Guan, Meishu Xu, Songrong Ren, Thomas D. Nolin, Youhua Liu, Wen Xie

MOLECULAR PHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

High molecular weight fibroblast growth factor 2 induces apoptosis by interacting with complement component 1 Q subcomponent-binding protein in vitro

Xiaobing Hong, Zelin Yu, Zhonglin Chen, Hongyan Jiang, Yongdong Niu, Zhanqin Huang

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Article Gastroenterology & Hepatology

Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice

Jiong Yan, Hung-Chun Tung, Sihan Li, Yongdong Niu, Wojciech G. Garbacz, Peipei Lu, Yuhan Bi, Yanping Li, Jinhan He, Meishu Xu, Songrong Ren, Satdarshan P. Monga, Robert F. Schwabe, Da Yang, Wen Xie

GASTROENTEROLOGY (2019)

Review Pharmacology & Pharmacy

PXR: a center of transcriptional regulation in cancer

Yaqi Xing, Jiong Yan, Yongdong Niu

ACTA PHARMACEUTICA SINICA B (2020)

Article Cell Biology

Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma

Li Zhang, Mengmeng Song, Fan Zhang, Hao Yuan, Wenjun Chang, Guanyu Yu, Yongdong Niu

Summary: The study identified that stromal NNMT expression is significantly increased in GC, predicting an unfavorable post-operative prognosis, with high expression significantly associated with tumor stage. However, patients with low stromal NNMT expression might respond better to adjuvant chemotherapy and have a more favorable prognosis.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2021)

Article Virology

Partial abrogation of FXR-KNG1 signaling by carboxyl-terminal truncated HBx-C30 in hepatitis B virus-associated hepatocellular carcinoma

Yongdong Niu, Liming Chen, Manpeng Wu, Weiyi Huang, Xuejun Wu, Danmei Huang, Yangmin Xie, Ganggang Shi

Summary: The study found that both full-length HBx and HBx C-terminal truncation coexist in HCC, and both can activate FXR signaling. Additionally, HBx-C30 has a weaker coactivating effect on FXR-KNG1 signaling compared to full-length HBx.

VIRUS RESEARCH (2021)

Article Chemistry, Multidisciplinary

N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice

Dai-Fei Shen, He Cheng, Bo-Zhi Cai, Wen-Feng Cai, Bin Wang, Qing Zhu, Yue-Bin Wu, Man Liu, Run-Ji Chen, Fen-Fei Gao, Yan-Mei Zhang, Yong-Dong Niu, Gang-Gang Shi

Summary: N-n-Butyl haloperidol iodide (F-2) demonstrates significant anti-fibrotic activity in mouse liver fibrosis by inhibiting c-Jun expression to reduce TGFBR2 levels and decrease the responsiveness of hepatic stellate cells to TGF-β 1.

ACTA PHARMACOLOGICA SINICA (2022)

Article Cell Biology

The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation

Xiaohua Huang, Bin Wang, Runji Chen, Shuping Zhong, Fenfei Gao, Yanmei Zhang, Yongdong Niu, Congzhu Li, Ganggang Shi

Summary: The study aimed to assess the mechanism of FXR in cervical cancer and found that FXR reduces cell viability, induces apoptosis, and promotes cell cycle arrest. FXR inhibits cervical cancer by upregulating SHP, MDM2, and p53.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer

Haoran Li, Zihao Qi, Yongdong Niu, Yufei Yang, Mengjiao Li, Yangyang Pang, Mingming Liu, Xi Cheng, Midie Xu, Ziliang Wang

Summary: FBP1 expression is significantly decreased in ovarian cancer tissues and low expression predicts poor prognosis. Enhanced FBP1 expression suppresses cancer cell proliferation and invasion, increases sensitivity to chemotherapy.

ONCOGENE (2021)

Article Plant Sciences

Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling

Hanif Khan, Zhengzhong Ni, Hai Feng, Yaqi Xing, Xuejun Wu, Danmei Huang, Ling Chen, Yongdong Niu, Ganggang Shi

Summary: This study evaluated the anti-tumor effect of curcumin in combination with F2 on hepatocellular carcinoma and found that the combination treatment significantly inhibited malignant proliferation and migration of HCC cells. The mechanism seemed to be associated with the downregulation of EZH2 and silencing of the Wnt/beta-catenin signaling pathway by interacting with H19, suggesting F2C may be a promising drug in the clinical treatment of HCC.

PHYTOMEDICINE (2021)

Article Multidisciplinary Sciences

Transcriptomic identification of HBx- associated hub genes in hepatocellular carcinoma

Zhengzhong Ni, Jun Lu, Weiyi Huang, Hanif Khan, Xuejun Wu, Danmei Huang, Ganggang Shi, Yongdong Niu, Haihua Huang

Summary: This study identified 12 key genes associated with HBx through RNA sequencing analysis of HepG2 cells overexpressing HBx, and validated their expression in HCC transcription profiles. Among these genes, the expression of ARG1 and TAT was correlated with a good prognosis in HCC patients.

PEERJ (2021)

Article Gastroenterology & Hepatology

Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling

Liming Chen, Yongdong Niu, Jiating Sun, Hong Lin, Guoxi Liang, Min Xiao, Dongmei Shi, Jia Wang, Huachen Zhu, Yi Guan

Summary: NDV/HK84 showed excellent oncolytic activity against HCC with minimal impact on healthy cells, and its activity was found to be dependent on the activation of type I interferon signaling based on RNA sequencing analysis.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

Different Expression Pattern of G Protein-Coupled Estrogen Receptor GPER1 in Esophageal Squamous Cell Carcinoma and Adenocarcinoma

Jingshi Liu, Yongdong Niu, Bin Zhang, Qisi Sun, Haiyi Li, Lu Bai, Zhongjing Su

Summary: The expression levels of GPER1 are found to be associated with tumor type and survival rates in esophageal carcinoma. In overall esophageal carcinoma, low expression of GPER1 is correlated with poor survival rates, while overexpression of GPER1 is associated with the development of esophageal adenocarcinoma and its pre-cancerous lesion. Furthermore, the protein expression of GPER1 is higher in esophageal adenocarcinoma tissues compared to normal esophageal tissues, whereas it is lower in esophageal squamous cell carcinoma tissues.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Gastroenterology & Hepatology

Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis

Yongdong Niu, Shaohua Fan, Qin Luo, Liming Chen, Danmei Huang, Wenjun Chang, Wenxin Qin, Ganggang Shi

Summary: HBV infection increases hepatocellular sensitivity to carcinogenic xenobiotics and promotes hepatocellular carcinoma formation. The HBx-PXR-CYP3A4/GSTM1-KRAS-IL11:IL11RA signaling axis plays a crucial role in enhancing the toxicity of chemical carcinogens in HBV-associated hepatocarcinogenesis.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2021)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)